维普期刊资源整合服务平台（V6.5）

328篇 您的检索式：作者名="Minckwitz"

选中清除导出查看参考文献查看引证文献引用追踪共17页首页上一页第1页下一页末页 /17 跳转

	题名	作者	年代	出处	被引量
1	Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers 显示文摘	Denkert C von Minckwitz G Brase JC	2015	J Clin Oncol2015，33，9：	1
2	Impact of treatment characteristics on response of different breast cancer pheno- types: pooled analysis of the German neo-adjuvant chemothera- py trials 显示文摘	Gunter yon Minckwitz Michael Untch	2011	Breast Cancer Res Treat2011，125，1：	1
3	Capecitabine: the new standard in metastatic breast cancer failing anthracycline and taxane containing chemotherapy? Mature results of a large multi-center phase II trial显示文摘	Reichardt P Von Minckwitz G Luck HJ et cd	2001	Eur J Cancer2001，37，6：	1
4	Definition and impact of pathologic complete response on prognosis after neoad- juvant chemotherapy in various intrinsic breast cancer subtypes 显示文摘	von Minckwitz G Untch M Blohmer JU	2012	JClinOncol2012，30，15：	1
5	Impact of treat- ment characteristics on response of different breast cancer pheno- types:pooled analysis of the German neo adjuvant chemotherapy trials显示文摘	Von Minckwitz G Untch M Nuesch E	2011	Breast Cancer Res Treat2011，125，1：	1
6	Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study显示文摘	Huober J yon Minckwitz G Denkert C	2010	Breast Cancer Res Treat2010，124，1：	1
7	Doxombicin with cyclophosphamide followed by docetaxel every 21 days compared with doxombicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group显示文摘	von Minckwitz G Raab G Caputo A	2005	J Clin Oncol2005，23，12：	1
8	Recommendations from an international expert panel on the use of neoadjuvant ( primary) systemic treatment of operable breast cancer: new perspectives 2006 显示文摘	Kaufmann M yon Minckwitz G Bear HD	2007	Ann Oncol2007，18，12：	1
9	Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase ~I study in HER2-positive breast cancer显示文摘	yon Minckwitz G Schwedler K Schmidt M	2011	Eur J Cancer2011，47，15：	1
10	Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase m randomized GeparTrio study 显示文摘	Von Minckwitz G kummel S vogel P	2008	J Natl Cancer Inst2008，100，：	1
11	Neoadjuvant car- boplatin in patients with triple-negative and HER2-positive early breast cancer( GeparSixto; GBG 66) : a randomised phase 2 trial 显示文摘	von Minckwitz G Schneeweiss A Loibl S	2014	Lancet Oncol2014，15，7：	1
12	Ki67 measured after neoadjuvant chemotherapy for primary breast cancer显示文摘	von Minckwitz G Schmitt WD Loibl S	2013	Clin Cancer Res2013，19，16：	1
13	In Vivo-chemosensitivity adapted primany chemotherapy in patients with primary breast cancer:First results of the GSPAR-TRZO pilottrial显示文摘	Von Minckwitz G Raab G Blohmer JU	2003	Eur J Cancer2003，1，5：	1
14	Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes显示文摘	yon Minckwitz G Untch M Blohmer JU	2012	J Clin Onco12012，30，15：	1
15	PARP is expssed in all subtypes of early breast cancer and is a predictive factor for response to neoadjuvant chemotherapy 显示文摘	Van Minckwitz G Muller B	2010	European Journal of Cancer Supplements2010，8，：	1
16	Selecting the neoadjuvant treatmentby molecular subtype : how to maximize the benefit 显示文摘	von Minckwitz G Fontanella C	2013	Breast2013，22，2：	1
17	Comparison of docetaxel/doxorubicin/cyclophosphamide (TAC) versus vinorelbine/capecitabine (NX) in patients non-responding to 2 cycles of neoadjuvant TAC chemotherapy-first results of the phase Ⅲ GEPARTRIO-Study by the German Breast Group显示文摘	yon Minckwitz G Blohmer J Loehr A	2005	Breast Cancer Res Treat2005，94，1：	1
18	Tumor-infiltrating lymphocytes in breast cancer: a new predictor for responses to therapy显示文摘	Issa-Nummer Y Loibl S Von Minckwitz G	2014	Oncoimmunology2014，3，27：	1
19	Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: New perspectives 2006显示文摘	Kaufmann M von Minckwitz G Bear HD	2007	Ann Oncol2007，18，12：	1
20	Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers显示文摘	Denkert C von Minckwitz G Brase JC	2015	J Clin Oncol2015，33，9：	1

返回顶部每页显示：

共17页首页上一页第1页下一页末页 /17 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示